Researchers have identified YAP and TAZ as crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis, ...

A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...

The safety of three therapeutic methods, each featuring electromagnetic navigation bronchoscopy-guided microwave ablation, was established in patients with multiple bilateral ground-glass opacities, ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

Qureight Ltd, a Core Imaging Laboratory developing deep-learning image analytics, and Vicore Pharma, a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 ...